Last updated on February 2019

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Brief description of study

This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) plus metronidazole, compared with that of meropenem in pediatric participants with cIAI.

Clinical Study Identifier: NCT03217136

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

Universiti Kebangsaan Malaya Medical Centre ( Site 1101)
Cheras, Malaysia
  Connect »

Study Coordinator

University Malaya Medical Centre. ( Site 1100)
Kuala Lumpur, Malaysia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.